Denali Therapeutics Cash Flow Statement (2017-2026) | DNLI

Cash Flow Statement Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-84.59M-75.26M-69.12M-58.79M-103.30M-98.68M-112.78M183.38M-99.35M-119.47M-104.59M-101.88M-110.08M-117.57M-135.87M-172.23M-129.88M-131.43M-129.01M-130.55M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
21.00M22.09M26.14M23.94M24.58M25.19M28.08M26.57M27.46M25.99M27.84M25.10M24.86M25.08M25.16M25.39M25.14M23.95M23.09M22.91M
Cash from Operations (Quarter)
-41.43M-65.49M-72.11M-42.90M-57.05M-72.66M-58.80M-113.17M-87.36M-98.66M-113.62M-91.22M-59.14M-83.72M-131.47M-75.30M-107.30M-98.54M-131.20M-97.00M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.40M0.80M0.89M0.90M0.90M0.92M0.92M0.92M
Depreciation & Amortization (CF) (Quarter)
2.19M2.10M2.08M2.07M2.14M4.11M10.05M2.29M2.22M2.18M2.16M1.94M1.84M1.85M2.33M3.04M2.95M2.87M2.85M3.57M
Change in Working Capital
Change in Account Payables (Quarter)
0.78M-0.08M1.25M0.84M1.90M-1.72M3.70M4.77M-3.96M-2.08M0.64M3.89M-4.37M1.29M-2.64M2.60M-4.07M-3.41M3.88M0.23M
Change in Accured Expenses (Quarter)
6.49M7.77M-8.31M5.87M9.33M4.03M19.81M-32.21M0.73M14.31M2.32M-20.82M24.59M-2.84M-9.69M-4.46M1.89M12.73M-22.39M3.29M
Other Working Capital Changes (Quarter)
-4.43M10.28M-27.91M-3.38M31.29M-0.38M
Investing Activities
Capital Expenditures (Quarter)
-0.20M8.47M0.11M6.82M-6.65M-0.28M6.08M2.56M-8.64M12.94M2.15M4.79M-5.76M0.01M5.08M4.28M-10.66M10.81M2.47M0.81M
Change in Acquisitions & Divestments (Quarter)
293.06M193.75M250.50M232.65M144.34M364.00M433.79M552.04M601.12M489.00M383.12M225.00M198.00M351.00M161.75M162.21M107.08M275.00M220.00M197.03M
Cash from Investing Activities (Quarter)
-53.01M-40.75M-117.88M88.63M15.42M-127.56M-92.72M168.07M100.91M73.05M-453.19M98.57M93.66M172.21M18.75M157.94M57.83M20.77M94.46M-104.08M
Financing Activities
Other financing activities (Quarter)
3.31M5.17M1.46M4.40M5.15M3.44M1.60M9.02M2.49M-13.12M1.02M6.76M5.46M4.16M0.59M4.06M0.58M3.22M6.70M15.01M
Change in Capital Stock
Shares Issued (Quarter)
Net Equity Issued and Repurchased (Quarter)
499.25M-499.25M12.37M
Misc.
Cash from Financing Activities (Quarter)
3.31M5.17M1.46M4.40M5.15M299.65M1.60M9.02M2.49M4.71M500.27M6.76M-18.56M-4.17M-3.76M1.62M-0.78M192.13M219.04M14.98M
Change in Cash (Quarter)
-91.13M-101.08M-188.52M50.13M-36.47M99.43M-149.91M63.92M16.04M-20.91M-66.53M14.11M15.96M84.32M-116.48M84.26M-50.24M114.36M182.30M-186.10M
Free Cash Flow (Quarter)
-41.23M-73.97M-72.22M-49.72M-50.40M-72.38M-64.88M-115.73M-78.73M-111.60M-115.77M-96.01M-53.38M-83.73M-136.55M-79.58M-96.64M-109.34M-133.67M-97.81M
Net Cash Flow (Quarter)
-91.13M-101.08M-188.52M50.13M-36.47M99.43M-149.91M63.92M16.04M-20.91M-66.53M14.11M15.96M84.32M-116.48M84.26M-50.24M114.36M182.30M-186.10M